A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
Titel:
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
Auteur:
Kunos, Charles Deng, Wei Dawson, Dawn Lea, Jayanthi S. Zanotti, Kristine M. Gray, Heidi J. Bender, David P. Guaglianone, Perry P. Carter, Jori S. Moore, Kathleen N.